5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide

C46H45F2N9O7 — CID 168875104

IUPAC5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide
SMILESO=C(CCCC(=O)N1CCC(n2cc(-c3cnc4cccc(-c5cc(F)c(CN6CCOCC6)c(F)c5)c4n3)cn2)CC1)NCc1ccc2c(c1)C(=O)N(C1CCC(=O)NC1=O)C2=O
InChIInChI=1S/C46H45F2N9O7/c47-35-20-28(21-36(48)34(35)26-54-15-17-64-18-16-54)31-3-1-4-37-43(31)52-38(24-49-37)29-23-51-56(25-29)30-11-13-55(14-12-30)42(60)6-2-5-40(58)50-22-27-7-8-32-33(19-27)46(63)57(45(32)62)39-9-10-41(59)53-44(39)61/h1,3-4,7-8,19-21,23-25,30,39H,2,5-6,9-18,22,26H2,(H,50,58)(H,53,59,61)
InChIKeyAZWTYMZEQHLQGY-UHFFFAOYSA-N
MW873.92 g/mol
LogP4.32
Rot. Bonds12

About 5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide

5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide (PubChem CID 168875104) has the molecular formula C46H45F2N9O7 and a molecular weight of 873.92 g/mol. Its IUPAC name is 5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide.

Molecular Properties

Compound Name5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide
PubChem CID168875104
Molecular FormulaC46H45F2N9O7
Molecular Weight873.92 g/mol
Exact Mass873.34
IUPAC Name5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide
SMILESO=C(CCCC(=O)N1CCC(n2cc(-c3cnc4cccc(-c5cc(F)c(CN6CCOCC6)c(F)c5)c4n3)cn2)CC1)NCc1ccc2c(c1)C(=O)N(C1CCC(=O)NC1=O)C2=O
InChIInChI=1S/C46H45F2N9O7/c47-35-20-28(21-36(48)34(35)26-54-15-17-64-18-16-54)31-3-1-4-37-43(31)52-38(24-49-37)29-23-51-56(25-29)30-11-13-55(14-12-30)42(60)6-2-5-40(58)50-22-27-7-8-32-33(19-27)46(63)57(45(32)62)39-9-10-41(59)53-44(39)61/h1,3-4,7-8,19-21,23-25,30,39H,2,5-6,9-18,22,26H2,(H,50,58)(H,53,59,61)
InChIKeyAZWTYMZEQHLQGY-UHFFFAOYSA-N
XLogP4.32
TPSA189.03 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds12
Heavy Atoms64
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500873.92
LogP ≤ 54.32
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide?
The IUPAC name of 5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide (CID 168875104) is 5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide.
What is the SMILES notation for 5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide?
The canonical SMILES for 5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide is O=C(CCCC(=O)N1CCC(n2cc(-c3cnc4cccc(-c5cc(F)c(CN6CCOCC6)c(F)c5)c4n3)cn2)CC1)NCc1ccc2c(c1)C(=O)N(C1CCC(=O)NC1=O)C2=O.
What is the InChIKey of 5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide?
The InChIKey is AZWTYMZEQHLQGY-UHFFFAOYSA-N. The full InChI is InChI=1S/C46H45F2N9O7/c47-35-20-28(21-36(48)34(35)26-54-15-17-64-18-16-54)31-3-1-4-37-43(31)52-38(24-49-37)29-23-51-56(25-29)30-11-13-55(14-12-30)42(60)6-2-5-40(58)50-22-27-7-8-32-33(19-27)46(63)57(45(32)62)39-9-10-41(59)53-44(39)61/h1,3-4,7-8,19-21,23-25,30,39H,2,5-6,9-18,22,26H2,(H,50,58)(H,53,59,61).
What are the key properties of 5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide?
5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide has a molecular weight of 873.92 g/mol, XLogP of 4.32, 12 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[4-[4-[8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]quinoxalin-2-yl]pyrazol-1-yl]piperidin-1-yl]-N-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-5-oxopentanamide is sourced from PubChem (CID 168875104), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).